Xia Meng

Xia Meng

Corporate Officer/Principal at CELLULAR BIOMEDICINE GROUP, INC.

Consumer Services
Health Technology
Commercial Services

Profile

Xia Meng is currently the Head-Early Diagnosis & Intervention at AbelZeta Pharma, Inc. Prior to this, Dr. Meng held positions as the Head-Institute Merieux Laboratory at Fudan University Shanghai Cancer Center, and as the General Manager at both Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
and Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd.
Dr. Meng completed an undergraduate degree at Wuhan University and a doctorate degree at Université Pierre et Marie Curie.

Xia Meng active positions

CompaniesPositionStart
CELLULAR BIOMEDICINE GROUP, INC. Corporate Officer/Principal 06/02/2018
All active positions of Xia Meng

Former positions of Xia Meng

CompaniesPositionEnd
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Xia Meng's experience

Training of Xia Meng

Wuhan University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Xia Meng's experience

Connections

17

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies5
Université Pierre et Marie Curie

Consumer Services

Health Technology

Commercial Services

Health Technology

Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd.

See company connections